share_log

Biohaven Shares Are Trading Higher After the Company Announced It Will Present Expanded Safety Data From Its BHV-7000 Multiple-dose Studies at the 2024 American Epilepsy Society Annual Meeting.

Biohaven Shares Are Trading Higher After the Company Announced It Will Present Expanded Safety Data From Its BHV-7000 Multiple-dose Studies at the 2024 American Epilepsy Society Annual Meeting.

Biohaven的股票在公司宣佈將於2024年美國癲癇協會年會上呈現其BHV-7000多劑量研究的擴展安全數據後交易上漲。
Benzinga ·  2024/12/06 21:59

Biohaven Shares Are Trading Higher After the Company Announced It Will Present Expanded Safety Data From Its BHV-7000 Multiple-dose Studies at the 2024 American Epilepsy Society Annual Meeting.

Biohaven的股票在公司宣佈將於2024年美國癲癇協會年會上呈現其BHV-7000多劑量研究的擴展安全數據後交易上漲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論